Date Filed | Type | Description |
08/21/2023 |
SC 13D/A
| Wolf Jeffrey Alan reports a 11.7% stake in NIGHTHAWK BIOSCIENCES, INC. |
12/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/03/2022 |
4
| Wolf Jeffrey Alan (CEO) has filed a Form 4 on HEAT BIOLOGICS, INC.
Txns:
| Disposed of 231,987 options to buy
@ $4.065, valued at
$943k
Granted 231,987 options to buy
@ $4.065, valued at
$943k
|
|
12/27/2021 |
4
| Wolf Jeffrey Alan (Director) has filed a Form 4 on Synthetic Biologics, Inc.
Txns:
| Granted 200,000 options to buy
@ $0.3314, valued at
$66.3k
|
|
12/16/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/03/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
01/03/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/02/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
12/05/2019 |
4
| Wolf Jeffrey Alan (Director) has filed a Form 4 on Synthetic Biologics, Inc.
Txns:
| Granted 250,000 options
@ $0.418, valued at
$104.5k
|
|
01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/07/2018 |
4
| Wolf Jeffrey Alan (Director) has filed a Form 4 on Synthetic Biologics, Inc.
Txns:
| Granted 79,500 options
@ $0.6895, valued at
$54.8k
|
|
01/10/2018 |
4
| Wolf Jeffrey Alan (CEO) has filed a Form 4 on HEAT BIOLOGICS, INC.
Txns:
| Granted 665,720 shares
@ $0 Granted 595,588 options
@ $0.4, valued at
$238.2k
|
|
12/21/2017 |
4
| Wolf Jeffrey Alan (Director) has filed a Form 4 on Synthetic Biologics, Inc.
Txns:
| Granted 200,000 options
@ $0.52, valued at
$104k
|
|
05/02/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
05/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/08/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/09/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
01/04/2017 |
4
| Wolf Jeffrey Alan (CEO) has filed a Form 4 on HEAT BIOLOGICS, INC.
Txns:
| Granted 75,000 shares
@ $0 Granted 125,000 shares
@ $0 Granted 75,000 options
@ $0.86, valued at
$64.5k
Granted 125,000 options
@ $0.88, valued at
$110k
|
|
12/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/04/2015 |
4
| Wolf Jeffrey Alan (Director) has filed a Form 4 on Synthetic Biologics, Inc.
Txns:
| Granted 125,000 options
@ $2.76, valued at
$345k
|
|
04/02/2015 |
4
| Wolf Jeffrey Alan (Director) has filed a Form 4 on Synthetic Biologics, Inc.
Txns:
| Exercised 10,842 shares
@ $0.09, valued at
$975.8 Exercised 10,842 options
@ $0 |
|
01/14/2015 |
4
| Wolf Jeffrey Alan (CEO) has filed a Form 4 on HEAT BIOLOGICS, INC.
Txns:
| Granted 12,500 options
@ $4.53, valued at
$56.6k
|
|
05/20/2014 |
4
| Wolf Jeffrey Alan (CEO) has filed a Form 4 on HEAT BIOLOGICS, INC.
Txns:
| Bought 1,754 shares
@ $4.15, valued at
$7.3k
Bought 400 shares
@ $4.05, valued at
$1.6k
Bought 346 shares
@ $4.1, valued at
$1.4k
|
|
04/21/2014 |
4
| Wolf Jeffrey Alan (Director) has filed a Form 4 on Synthetic Biologics, Inc.
Txns:
| Granted 105,000 options to buy
@ $2.52, valued at
$264.6k
|
|
|